From potential to performance.

Our market-based approach identifies the most promising life science startups, and supports them throughout the journey. We engage deeply in every aspect of the business, leveraging our network to tackle each company’s specific challenges and lead them to successful Series A investments with world-class VCs and strategic investors.


We begin with a deep dive into the prospect company to examine management and strategic needs, leadership team, space requirements, and current funding. At every turn, we’re assessing opportunity and fit.

  • Rigorous research and market understanding
  • Seeking emerging technologies and novel approaches to big problems
  • Build portfolio of high-potential biopharma, med tech, and data sciences ventures

Once selected, we begin our collaboration with company founders. We understand the many complexities of the biotech business model, and bring deep experience to help startups answer defining strategic questions, overcome roadblocks, and build capability and confidence.

  • Support key regulatory and clinical decisions
  • Optimize manufacturing and commercial considerations

In the build stage, we work side-by-side with company founders to nurture and accelerate growth. We craft a robust strategic roadmap for value creation, and execute together with urgency and action.

  • 12–18 months
  • Vested interest in growth and value creation
  • Best-in-class business operations, financial and strategic partnerships, and lab equipment

From day one, we work with the end game in mind: prosperous execution. We guide our portfolio companies toward the most favorable next step in their journey, be it acquisition or strategic partnership.

  • Expertise, partnership, and trust to drive successful outcomes
  • Lasting, positive impact